Cancer News and Research

Latest Cancer News and Research

Progeria-derived iPS cells may treat aging-related disease in children

The current pace of population aging is without parallel in human history but surprisingly little is known about the human aging process, because lifespans of eight decades or more make it difficult to study. Now, researchers at the Salk Institute for Biological Studies have replicated premature aging in the lab, allowing them to study aging-related disease in a dish.

24 Feb 2011

Scientists find bovine colostrum can massively reduce leaky gut syndrome

Scientists investigating natural ways to enhance athletic performance have found that bovine colostrum can massively reduce gut permeability - otherwise known as 'leaky gut syndrome.'

24 Feb 2011

Scientists suggest new vitamin D-fortified bread can solve insufficiency problem

With most people unable to get enough vitamin D from sunlight or foods, scientists are suggesting that a new vitamin D-fortified food - bread made with high-vitamin D yeast - could fill that gap. Their study, confirming that the approach works in laboratory tests, appears in ACS' Journal of Agricultural and Food Chemistry.

24 Feb 2011

Viewpoints: GOP's 'war' on family planning; state workers' health costs; health law already hurting U.S.

A bill passed by the Republican-controlled House last week would cut $75 million in funding to Planned Parenthood that is spent for family planning assistance.

24 Feb 2011

Scientists complete protein 3D structural sequence essential for cellular function

Researchers at IRB Barcelona have completed the 3D structural sequence adopted by several essential proteins in the exchange of substances between the extra and intracellular milieu. This finding provides a global perspective of the structural changes that occur in these relevant proteins during basic cell processes, such as protein synthesis, the regulation of metabolism and cell volume, and nerve transmission.

24 Feb 2011

New vaccine offers hope against Hepatitis C

Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark.

24 Feb 2011

Nonsurgical methods to identify critical lymph nodes in patients with breast cancer

Researchers at the University of California, San Diego are developing nonsurgical methods for identifying critical lymph nodes to help doctors determine courses of treatment for breast cancer patients.

24 Feb 2011

EpiCept 2010 fourth quarter net loss is $0.06 per share

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.

24 Feb 2011

ViewRay's radiotherapy treatment planning and delivery software receives FDA marketing clearance

ViewRay™, Inc., a privately held medical device company, has received U.S. FDA marketing clearance for its radiotherapy treatment planning and delivery software.

24 Feb 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.

From Cell Signaling Technology 24 Feb 2011

Oncolytics completes patient enrollment in REOLYSIN trial to treat metastatic colorectal cancer

Oncolytics Biotech Inc. announced today that enrollment has been completed in a U.K. translational clinical trial investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases.

23 Feb 2011

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

PCI Biotech the Norwegian biopharmaceutical company, reported today that it has completed the inclusion of patients in its phase I/II study of its lead candidate PC-A11 in cancer patients.

23 Feb 2011

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

Whether on a battlefield, in a factory or at a rock concert, noise-induced hearing loss is one of the most common hazards people face. Researchers at Washington University School of Medicine in St. Louis have identified a low-dose, two-drug cocktail that reduces hearing loss in mice when given before they are exposed to loud noise. The drugs, already FDA-approved for other conditions, also treat hearing loss after noise exposure.

23 Feb 2011

FDA clears Agendia's breast cancer recurrence assay

Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration clearance for MammaPrint, its widely used breast cancer recurrence assay.

23 Feb 2011

FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML

Sunesis Pharmaceuticals, Inc. today announced that vosaroxin, the Company's lead drug candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration for the potential treatment of relapsed or refractory acute myeloid leukemia in combination with cytarabine.

23 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Cell phones may lead to stimulation of parts of brain - Speculation on cancer continues

There is still debate as to whether cell phones damage the brain. The cell phone industry, along with nearly all major national and international medical associations have always responded with the same answer that there is no evidence that cell phone radiation can even affect the brain, let alone cause cancer.

23 Feb 2011

Toxic contamination of groundwater: South Australia residents warned

Australia’s Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.

23 Feb 2011

Aeterna to present two novel anticancer compounds at Bio Partnering North America conference

Aeterna Zentaris Inc. today announced that its Vice President, Alliance Management and Intellectual Property, Eckhard Guenther, Ph.D., will make a presentation on two of the Company's novel anticancer compounds, AEZS-108 and AEZS-129, at Bio Partnering North America on Monday, February 28, 2011, at 4 p.m. in the West Meeting Room 218, of the Vancouver Convention Center in Vancouver, Canada.

23 Feb 2011

Cancer News and Research

Latest Cancer News and Research

Progeria-derived iPS cells may treat aging-related disease in children

Scientists find bovine colostrum can massively reduce leaky gut syndrome

Scientists suggest new vitamin D-fortified bread can solve insufficiency problem

Viewpoints: GOP's 'war' on family planning; state workers' health costs; health law already hurting U.S.

Scientists complete protein 3D structural sequence essential for cellular function

New vaccine offers hope against Hepatitis C

Nonsurgical methods to identify critical lymph nodes in patients with breast cancer

EpiCept 2010 fourth quarter net loss is $0.06 per share

ViewRay's radiotherapy treatment planning and delivery software receives FDA marketing clearance

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

Oncolytics completes patient enrollment in REOLYSIN trial to treat metastatic colorectal cancer

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice

FDA clears Agendia's breast cancer recurrence assay

FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML

Australia’s top scientist takes on top job

Cell phones may lead to stimulation of parts of brain - Speculation on cancer continues

Toxic contamination of groundwater: South Australia residents warned

Aeterna to present two novel anticancer compounds at Bio Partnering North America conference

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in